26.94USD+0.52%Mkt Cap: 1.43B USDP/E: —Last update: 2026-06-01
KalVista Pharmaceuticals, Inc., a biopharmaceutical company, develops oral therapies for individuals for rare diseases with unmet needs. Its lead product candidate is EKTERLY, a fast-acting potent inhibitor of plasma kal…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.43B USD
Enterprise Value1.43B USD
Revenue (TTM)114.48M USD
Gross Profit58.47M USD
Net Income (TTM)-183.44M USD
Revenue/Share2.110 USD
Last Price26.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees275
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS4834971032
Valuation
P/E (Trailing)—
P/E (Forward)22.45
PEG—
EV/EBITDA-10.33
EV/Revenue12.49
P/S12.50
P/B-506.98
EPS (TTM)-3.94
EPS (Forward)1.20
52W Range
9.830100% of range26.98
52W High26.98 USD
52W Low9.830 USD
Profitability
Gross Margin51.07%
Oper. Margin-57.37%
EBITDA Margin-120.94%
Profit Margin-118.74%
ROE6766.65%
ROA-54.70%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-152.91M USD
CapEx (TTM)929.00K USD
FCF Margin—
FCF Yield—
Net Debt-718.02K USD
Net Debt/EBITDA0.01
Balance Sheet
Debt/Equity-55.91
Current Ratio5.17
Quick Ratio4.97
Book Value/Sh-0.0530 USD
Cash/Share5.354 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateNov 22, 2016
Splits
Last Split1:14
Split DateNov 22, 2016
Analyst Consensus
Rating2.7 (Hold)
Target (Mean)28.60 USD
Target Range27.00 USD – 35.00 USD
# Analysts5
Ownership
Shares Out.53.24M
Float38.19M
Insiders1.72%
Institutions131.35%
Short Interest
Short Ratio2.0d
Short % Float25.31%
Short % Out.22.64%
Shares Short12.05M
Short (prev mo.)19.65M
Technical
SMA 5022.27 (+21.0%)
SMA 20016.21 (+66.2%)
Beta-0.12
S&P 52W Chg27.94%
Avg Vol (30d)5.41M
Avg Vol (10d)4.26M
Technical Indicators
RSI (14)74.6
MACD1.2344
MACD Signal1.5179
MACD Hist.-0.2835
BB Upper26.84 USD
BB Middle26.75 USD
BB Lower26.66 USD
BB Width0.69%
ATR (14)0.3955 USD
Vol Ratio (20d)0.21x